Reporting on the real-world utilization of reference rituximab and its biosimilars can help show prescribing habits and reveal cost-saving opportunities.
Michelle Winkler, PhD, MPH
Advertisement
Articles by Michelle Winkler, PhD, MPH
Advertisement
Latest Updated Articles
Rituximab Reference vs Biosimilar Utilization for Oncology vs Nononcology IndicationsPublished: November 9th 2023 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Maternal, Child Mortality Higher in the US Compared With Majority of High-Income Countries
2
FDA Approves Second Generic Mifepristone Pill for Abortion
3
EASO Recommends Semaglutide, Tirzepatide for First-Line Obesity Therapy
4
Withdrawal of Aid Could Cause Millions of Lives Lost to HIV
5
